Quadrant Capital Group’s Acutus Medical Inc AFIB Stock Holding History

Quadrant Capital Group’s Portfolio AFIB Stock Details AFIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-46	Closed	–	–	2745
2021 Q3	$0	Sell	46 -476	-91%	-$6.26K	﹤0.01%	2695
2021 Q2	$9K	Buy	+522	New	+$7.64K	﹤0.01%	1644

Other funds holding AFIB

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KSCM

Kamunting Street Capital Management Miami Beach, Florida $179M AUM 5.77% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Quadrant Capital Group's AFIB Position: Q4 2021 in Review

Quadrant Capital Group sold out of Acutus Medical Inc (AFIB) in Q4 2021, closing a stake of 46 shares.

Quadrant Capital Group first reported a position in AFIB in Q2 2021 and held it in 2 quarters. The position peaked at $9K in Q2 2021. 71 funds tracked by Wall St. Rank hold AFIB as of Q4 2021.

Quadrant Capital Group reported no remaining Acutus Medical Inc position as of Q4 2021 after selling out during the quarter.
Quadrant Capital Group sold 46 Acutus Medical Inc shares in Q4 2021.
Quadrant Capital Group first reported a position in Acutus Medical Inc in Q2 2021 and held it in 2 quarters.
Quadrant Capital Group's Acutus Medical Inc position peaked at $9K in Q2 2021.
71 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2021.

Based on Quadrant Capital Group's 13F filing for Q4 2021, filed 1 Feb 2022.